Stay updated on Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.3.2 appears in the page footer, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T03:28:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows revision v3.3.1, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-21T01:41:09.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A government funding/operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-13T22:17:24.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    No significant content changes detected; core study details remain the same, with only minor UI differences, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-30T12:27:14.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Introducing a government funding notice and current operating status for the NIH Clinical Center, along with updating the version to v3.2.0 and removing v3.0.2.
    Difference
    2%
    Check dated 2025-10-01T14:20:36.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Removed core topics related to drug safety and quality (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), significantly narrowing the page's scope.
    Difference
    0.2%
    Check dated 2025-09-24T09:46:30.000Z thumbnail image

Stay in the know with updates to Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis Clinical Trial page.